Anukanon, S., Teerapatarakan, N. and Hankitichai, P. 2026. Computational Analysis of FDA-Approved Drugs for Potential Repurposing in Alzheimer’s Disease: Targeting mTOR and NGFR Pathways. Science Essence Journal. 42, 1 (Jan. 2026), 50–70.